Lien Van Eyck
Clinical Development Lead
Astrivax
Leuven, Belgium
Accountable for the design, conduct and analysis of the Phase I-II Clinical Development activities for multiple vaccine programs at Astrivax Therapeutics
About me
Dr Lien Van Eyck is a paediatrician and mechanical engineer. She holds a PhD in Immunology, focusing on the identification of disease-causing genetic variants in patients with severe early-onset immunological disorders. After training as a paediatrician, she transitioned to the pharmaceutical industry, gaining extensive experience in early-phase clinical trials, vaccine development and medical affairs at Pfizer and GSK. During her time at Pfizer, she completed a post-graduate program in pharmaceutical development sciences. She currently serves as Clinical Development Lead at Astrivax Therapeutics in Leuven, Belgium.
My organisation
AstriVax NV is a privately held Belgian company founded in 2022 based on vaccine technology developed at the Rega Institute (KU Leuven). AstriVax is developing a first-in-class Plug & Play vaccine platform, for the development of prophylactic and therapeutic vaccines.
Skills
- clinical research
- Immunology
- İnfectious disease
- early-phase clinical trials
- vaccine development
- Pediatrics
Additional questions
How would you categorise yourself?
Organisation Type
Areas of expertise
Therapeutic areas
1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.
I agree